4//SEC Filing
Germa Caroline 4
Accession 0000950170-24-025870
CIK 0001835579other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:05 PM ET
Size
5.3 KB
Accession
0000950170-24-025870
Insider Transaction Report
Form 4
Germa Caroline
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+579,100→ 579,100 totalExercise: $1.47Exp: 2034-03-01→ Common Stock (579,100 underlying)
Footnotes (1)
- [F1]12.5% of the shares subject to this option shall vest and become exercisable on September 1, 2024, with the remainder vesting in forty-two (42) equal monthly installments thereafter.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0002013288
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:05 PM ET
- Size
- 5.3 KB